Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 5

Results For "contract"

603 News Found

AI will eliminate 70-80% of current pharma commercial processes: Dushyant Sapre, Founder and CEO, SwishX
interviews | May 13, 2026

AI will eliminate 70-80% of current pharma commercial processes: Dushyant Sapre, Founder and CEO, SwishX

We are building an AI-native operating system for pharma sales and distribution


Plus Therapeutics subsidiary clears key Medicare milestone
News | May 12, 2026

Plus Therapeutics subsidiary clears key Medicare milestone

Paves way for CNS cancer test rollout


SwishX raises $2.2 million seed to launch agentic AI for pharma and MedTech
Digitisation | May 12, 2026

SwishX raises $2.2 million seed to launch agentic AI for pharma and MedTech

Bengaluru startup targets 100+ enterprise clients and global expansion as it aims to transform pharmaceutical sales, marketing, tenders, and distribution using AI agents


From lab bench to market: Strengthening translational research in India’s biotech ecosystem
Opinion | May 11, 2026

From lab bench to market: Strengthening translational research in India’s biotech ecosystem

India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells


6th Drug Safety Symposium 2026 to convene over 100 pharmacovigilance leaders
Clinical Trials | May 11, 2026

6th Drug Safety Symposium 2026 to convene over 100 pharmacovigilance leaders

Mumbai event on June 24–25 will spotlight real-world impact of pharmacovigilance beyond AI adoption


Lonza surges on biologics boom
News | May 09, 2026

Lonza surges on biologics boom

Expands manufacturing push & locks in major growth deals


Neuland Labs and LIR Life partner on next-gen transdermal GLP-1 obesity therapy platform
News | May 07, 2026

Neuland Labs and LIR Life partner on next-gen transdermal GLP-1 obesity therapy platform

LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity


CARBOGEN AMCIS Shanghai site clears unannounced NMPA GMP inspection
News | May 07, 2026

CARBOGEN AMCIS Shanghai site clears unannounced NMPA GMP inspection

Successful inspection outcome strengthens company’s regulatory compliance and manufacturing standards in China


Laurus Labs Q4 profit rises to Rs. 279 crore, FY26 revenue up 23%
News | May 06, 2026

Laurus Labs Q4 profit rises to Rs. 279 crore, FY26 revenue up 23%

The company reported robust revenue and profit growth for FY26, supported by strong CDMO performance, improving margins, and expansion across advanced manufacturing platforms


SK Capital sells Noramco assets to Siegfried
News | May 05, 2026

SK Capital sells Noramco assets to Siegfried

Keeps Halo Pharma to drive independent growth